BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 30, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 8, 2014
View Archived Issues
Phase I results presented for the new PET tracer [18F]-FSPG
Read More
Foamix begins phase II trial of FDX-104 to prevent EGFR inhibitor-induced rash
Read More
Merck Serono, the ICR and the Wellcome Trust collaborate to discover tankyrase inhibitors
Read More
NanoString Technologies and Brigham and Women's Hospital collaborate to develop cancer diagnostics
Read More
MicroRNA identified as a biomarker target for MS
Read More
Interim phase II results for squalamine lactate plus ranibizumab in neovascular AMD
Read More
SNP signature linked to response to glatiramer in patients with MS
Read More
AbbVie discloses novel CDK9/cyclin-T1 inhibitors for cancer
Read More
BNN-93, a novel neuroprotective ocular solution
Read More
Researchers at Oncodesign patent novel RIP-2 inhibitors
Read More
Sanofi divulges new SGK1 inhibitors
Read More
Researchers in London prepare novel SSAO inhibitors for COPD and other disorders
Read More
A team of scientists at Novartis synthesize new complement C5 convertase inhibitors
Read More
FDA grants orphan drug status to DNX-2401 for glioma
Read More
MacroGenics begins phase I study of MGD-007
Read More
FDA grants fast track designation to NurOwn for ALS
Read More
DiscoveryBioMed receives grant for ADPKD drug development
Read More
StemCells begins phase II trial of HuCNS-SC in cervical SCI
Read More
NIAID awards grant to Hampton University for work in infectious disease
Read More
Bristol-Myers Squibb withdraws NDA for asunaprevir
Read More
Generex Biotechnology explores opportunities for Antigen Express technology against Ebola
Read More
Orphazyme prepares phase II/III trial of arimoclomol in Niemann-Pick disease type C
Read More
Lead Discovery Center and UiT The Arctic University of Norway seek drugs in arctic sea organisms
Read More
Second Genome partners with Mayo Clinic to develop microbiome therapeutics
Read More
Cardio3 BioSciences gains preferred access to Mayo Clinic technologies
Read More
